Evidence map›Paper›PMID 33827580›Full record

ReviewJournal of biomedical science2021

Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.

Yu-Chen S H Yang, Po-Jui Ko, Yi-Shin Pan, Hung-Yun Lin, Jacqueline Whang-Peng, Paul J Davis, Kuan Wang

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of biomedical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma.International journal of medical sciences · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Microbiology spectrum · 2024
    Article
  12. Article
  13. Preclinical evaluation of a dual-receptor targeted tracer [European journal of nuclear medicine and molecular imaging · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Evaluation of integrin αCancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Article
  19. Article
  20. Toxicologic Concerns with Current Medical Nanoparticles.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Yu-Chen S H Yang *Joint Biobank, Office of Human Research, Taipei Medical University, Taipei, 11031, Taiwan.
Po-Jui Ko *School of Medicine, I-Shou University, Kaohsiung, 84001, Taiwan.
Yi-Shin PanGraduate Institute of Nanomedicine and Medical Engineering, College of Medical Engineering, Taipei Medical University, Taipei, 11031, Taiwan.
Hung-Yun LinGraduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, 11031, Taiwan. linhy@tmu.edu.tw.ORCID http://orcid.org/0000-0003-2824-6419
Jacqueline Whang-PengGraduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, 11031, Taiwan.
Paul J DavisPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, NY, 12144, USA.
Kuan WangGraduate Institute of Nanomedicine and Medical Engineering, College of Medical Engineering, Taipei Medical University, Taipei, 11031, Taiwan.
Taipei Medical University · TWAlbany College of Pharmacy and Health Sciences · USE-Da Hospital · TWTaipei Medical University Hospital · TWWan Fang Hospital · TW

Funding

E-Da Medical Center EDAHP 109011
6 · The paper itself

Abstract

Thyroid hormone analogues-particularly, L-thyroxine (T

Indexed as

Signal TransductionAntineoplastic AgentsColorectal NeoplasmsGenes, erbB-1Genes, rasHumansIntegrin alphaVbeta3ThyroxineAntineoplastic AgentsIntegrin alphaVbeta3ThyroxineColorectal CancerEpidermal growth factor receptorIntegrin αvβ3NDATRas mutation

Identifiers

PMID33827580
PMCPMC8028191
OpenAlexW3150804929

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.